Biology Reference
In-Depth Information
242. Andreassen CN, Alsner J, Overgaard M, et al. Risk of radiation-
induced subcutaneous fibrosis in relation to single nucleotide
polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and
ATM
e
a study based on DNA from formalin fixed paraffin
embedded tissue samples. Int J Radiat Biol 2006;
breast radiotherapy in the United Kingdom. Clin Cancer Res
2006;
:7025
e
32.
250. Shanley S, McReynolds K, Ardern-Jones A, et al. Acute chemo-
therapy-related toxicity is not increased in BRCA1 and BRCA2
mutation carriers treated for breast cancer
12
:577
e
86.
243. Bremer M, Klopper K, Yamini P, Bendix-Waltes R, Dork T,
Karstens JH. Clinical radiosensitivity in breast cancer patients
carrying pathogenic ATM gene mutations: no observation of
increased radiation-induced acute or late effects. Radiother Oncol
2003;
82
in the United
:7033
e
8.
251. Mangoni M, Bisanzi S, Carozzi F, et al. Association between
genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1,
GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosen-
sitivity in breast cancer patients. Int J Radiat Oncol Biol Phys; 2010.
August 11 [Epub ahead of print].
252. Zhou L, Xia J, Li H, Dai J, Hu Y. Association of XRCC1 variants
with acute skin reaction after radiotherapy in breast cancer
patients. Cancer Biother Radiopharm 2010;
Kingdom. Clin Cancer Res 2006;
12
:155
e
60.
244. Chang-Claude J, Popanda O, Tan XL, et al. Association between
polymorphisms in the DNA repair genes, XRCC1, APE1, and
XPD and acute side effects of radiotherapy in breast cancer
patients. Clin Cancer Res 2005;
69
:4802
e
9.
245. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J.
Polymorphisms in the DNA repair gene XRCC1, breast cancer
risk, and response to radiotherapy. Cancer Epidemiol Biomarkers
Prev 2003;
11
:681
e
5.
253. De Ruyck K, Van Eijkeren M, Claes K, et al. Radiation-induced
damage to normal tissues after radiotherapy in patients treated
for gynecologic tumors: association with single nucleotide poly-
morphisms in XRCC1, XRCC3, and OGG1 genes and in vitro
chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol
Biol Phys 2005;
25
:1168
e
74.
246. Price EA, Bourne SL, Radbourne R, Lawton PA, Lamerdin J,
Thompson LH, et al. Rare microsatellite polymorphisms in the
DNA repair genes XRCC1, XRCC3 and XRCC5 associated with
cancer in patients of varying radiosensitivity. Somat Cell Mol
Genet 1997;
12
:1140
e
9.
254. Severin DM, Leong T, Cassidy B, et al. Novel DNA sequence
variants in the hHR21 DNA repair gene in radiosensitive cancer
patients. Int J Radiat Oncol Biol Phys 2001;
62
:237
e
47.
247. Popanda O, Tan XL, Ambrosone CB, et al. Genetic poly-
morphisms in the DNA double-strand break repair genes
XRCC3, XRCC2, and NBS1 are not associated with acute side
effects of radiotherapy in breast cancer patients. Cancer Epidemiol
Biomarkers Prev 2006;
23
:1323
e
31.
255. Zhang S, Li Q, Zhang Q, et al. Expression of ERCC1 and class III
ss-tubulin in resected non-small cell lung cancer and its correla-
tion with platinum-based adjuvant chemotherapy.
50
Int
J Biol
:1048
e
50.
248. Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction
of normal tissue radiosensitivity from polymorphisms in candi-
date genes. Radiother Oncol 2003;
15
:141
e
9.
256. Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N.
Association between normal tissue complications after radio-
therapy and polymorphic variations in TGFB1 and XRCC1 genes.
Radiat Res 2010;
Markers 2010;
25
:127
e
35.
249 Shanley S, McReynolds K, Ardern-Jones A, et al. Late toxicity is
not increased in BRCA1/BRCA2 mutation carriers undergoing
69
173
:505
e
11.
